CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Exactus Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Exactus Inc
80 NE 4th Ave Ste 28
Phone: (804) 205-5036p:804 205-5036 DELRAY BEACH, FL  33483-4564  United States Ticker: EXDIEXDI

On 3/15/2019, the Company filed a Registration Withdrawal Request of its Form S-1 (File No. 333-220425) with the SEC, initially filed with the Commission on September 11, 2017. The Company is seeking withdrawal of the Registration Statement because it has determined to not seek a public offering at this time.

Business Summary
Exactus, Inc. is a healthcare company. The Company is focused on manufacturing hemp derived Cannabidiol (CBD) products. It sells its CBD products through its Exactus brand and white label products to third-party resellers. It is also engaged in producing industrial hemp from farms in Oregon. Its products product line includes hemp flower, pre-rolled hemp flower, topicals, tinctures and concentrates. It also offers point-of-care diagnostic tools to analyze biometric markers in a drop of blood. Its FibriLyzer product provides solution to assess the fibrinolytic status of patients in a broad range of applications, including surgery, trauma, orthopedics, heart, stroke and chronic coronary disease management. Its MatriLyzer product detects the initial occurrence or the recurrence of cancer during routine office visits.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
IRA CQ
Score
Moody's
Rating
Fitch
Rating
DBRS
Rating
Morningstar
Rating
-Yes-------

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/201912/31/2018YesYes-YesYes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Interim Executive Chairman of the Board VladislavYampolsky 42 8/21/2019 6/24/2019
President, Interim Chief Executive Officer Emiliano A.Aloi 8/21/2019 3/21/2019
Chief Financial Officer, Director Kenneth E.Puzder 53 7/15/2019 1/9/2019
5 additional Officers and Directors records available in full report.

Business Names
Business Name
Exactus BioSolutions, Inc.
EXDI
EXDID
Green Goddess Extracts
LeVor Collection Ltd
SGYTD

General Information
Number of Employees: 4 (As of 12/31/2018)
Outstanding Shares: 41,244,807 (As of 11/13/2019)
Shareholders: 113
Stock Exchange: OTC
Federal Tax Id: 271085858
Fax Number: (917) 210-2846


Copyright © 2019 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, December 07, 2019